The Differences Between Interact 2 and Interact 3 Trials

There are a couple of different mythological differences between the two studies in particular of what patients they ended up enrolling. Interact 2 allowed studies to use whatever antihypertension they had available and attached to mandated the use of nichardipede so there's at least a little bit of homogeneity in what therapy was used which I think is particularly helpful for us to assess whether or not the treatment that was actually implemented had a major outcome but at the bottom line like they included relatively not super sick ICH patients with relatively elevated blood pressures.